NEIDL in the News

Dr. Nahid Bhadelia: ‘The lack of a coordinated national plan’ is the cause of delays in Covid-19 vaccine distribution

Original article from MSNBC by Craig Melvin. January 4, 2021 MSNBC’s Yasmin Vossoughian is joined by infectious disease physician and Boston University professor, Dr. Nahid Bhadelia to discuss delays in the administration of the Covid-19 vaccine and AstraZeneca vaccine approval in the U.S. Click to Watch more on MSNBC

Yes to Masks. No to Parties. 2021 Will Be a Lot Like 2020

Original article from WIRED by Maryn Mckenna. December 31, 2020 Sorry, folks: Thanks to Covid, next year won’t be much more fun than this one, at least until enough vaccines arrive.. The morning of November 11, 1918, dawned cool and drizzly in France. It wasn’t quiet, though. The Armistice that stopped what... More

The COVID-19 Vaccines: Everything You Need to Know

Original article from The Brink by Kat J. McAlpine. December 16, 2020 With a long-awaited coronavirus vaccine finally shining a light at the end of the long, dark tunnel that has been 2020, The Brink reached out to Boston University COVID-19 experts Davidson Hamer and Judy Platt for answers to so... More

Infectious Disease Specialist Games Out When Most People Will Get Access To COVID-19 Vaccine (Interview with Dr. Nahid Bhadelia)

Original interview from GBH. November 30, 2020 Moderna announced Monday that it was officially submitting its coronavirus vaccine to the FDA for emergency use approval, following in the footsteps of Pfizer, with a target date of December 21 to start delivering the first injections. But significant questions remain regarding the logistics... More

After Promising Moderna Results, A Public Health Expert Breaks Down The Race For A Vaccine (Interview w/ Dr. Hamer)

Original article from WBUR CommonHealth by Bob Oakes. November 16, 2020 Shares in Cambridge-based Moderna are soaring in premarket trading following positive news about its experimental COVID-19 vaccine. The company reported Monday that thee vaccine was nearly 95% effective in preventing the virus in early U.S. trials. The news comes a week after... More

In Deadly COVID-19 Lung Inflammation, BU Researchers Discover a Culprit in NFkB Pathway

Original article from The Brink by Kat J. McAlpine. September 24, 2020 As the coronavirus pandemic ripped through through the United States in March, scientists at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) and the Center for Regenerative Medicine (CReM) dropped all other research to focus exclusively on the SARS-CoV-2... More

The lasting misery of coronavirus long-haulers

Original article from Nature by Michael Marshall. September 14, 2020 The lung scans were the first sign of trouble. In the early weeks of the coronavirus pandemic, clinical radiologist Ali Gholamrezanezhad began to notice that some people who had cleared their COVID-19 infection still had distinct signs of damage. “Unfortunately, sometimes... More